Detection of bone marrow involvement with FDG PET/CT in patients with newly diagnosed lymphoma.
Conclusion: Our results suggest that BMI should not be decided solely based PET/CT or BMB findings. It is reasonable to use both diagnostic assays along with clinical and laboratory findings. PET/CT result, clinical and laboratory findings could be useful for predicting BMI in patient for whom BMB is contraindicated.
PMID: 30588464 [PubMed]
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research
More News: Bone Marrow Aspiration and Biopsy | CT Scan | Laboratory Medicine | Lymphoma | PET Scan | Study